896663

Alexion Pharmaceuticals, Inc. — FEI 3006031727

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 26, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Haven, CT (United States)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report
683221 CFR 314.80(c)(2)Late submission of annual safety reports